Omaha System-Based Health Application on Improving Knowledge, Attitude, and Behaviors Regarding Infectious Disease Prevention in the Community

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorKocaeli University

About this trial

Background: Infectious diseases remain significant public health concerns due to several factors such as climate and environmental changes and natural disasters. Mobile health applications (mHealth apps) can be an appropriate way for fostering community participation, disseminating knowledge, and promoting behavior change toward infectious disease prevention. This study aims to describe a protocol for a pilot randomized controlled study to evaluate the impact of the Omaha System-Based mHealth app (BUHOS) on improving knowledge, attitude, and behaviors (KAB) regarding infectious disease prevention in an earthquake-affected region of Türkiye.

Methods: This study is a two-armed, parallel-group, randomized controlled trial design. A total of 112 eligible participants will be recruited from two separate container cities of an earthquake-affected region. These participants will be randomly allocated to either an intervention group or a control group. BUHOS will be designed based on the Omaha System, a widely recognized standardized taxonomy for the assessment, planning, and evaluation of healthcare services. BUHOS will be a two-week nursing intervention that includes monitoring KAB, employing Education, Guidance and Counseling (education videos), and Surveillance (reminder messages), and assessing the outcomes. Outcome variables will include the Problem Rating Scale for Outcomes, Community Communicable Diseases Knowledge Survey, Communicable Diseases Risk Awareness and Protection Scale and System Usability Scale. Outcome variables will be assessed on the 15th and 30th day after intervention.

Hypotheses:

H1: Among the Omaha System Problems, the Communicable/ Infectious Condition Problem Knowledge score will be higher on the 15th and 30th days compared to the control group.

H2: Infectious diseases risk awareness and prevention score will be higher on the 15th and 30th days compared to the control group.

H3: Communicable/ Infectious Condition Status Behaviour Parameter score will be higher on the 15th and 30th days compared to the control group H4: The knowledge and behaviour of the communicable/ infectious status and the awareness and prevention of the risk of infectious diseases of the experimental group will be higher than before the intervention on the 15th and 30th days.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

being aged between 18 and 64 years,

living in two container cities,

having a knowledge score of 'very low (1)' and 'low (2)' on the Omaha System Problem Rating Scale for Outcome for Communicable/ Infectious Problem Knowledge Parameter,

being literate,

Disqualifiers

having impaired vision or hearing,

having a mental illness,

not owning a smartphone,

being pregnant or postpartum,

Trial design

Design model

Parallel

Treatments tested in this trial

  • BUHOS app

    Other intervention

    In this study, the BUHOS app initiative will be implemented among participants in the intervention group. BUHOS will be a two-weeks nursing intervention that includes monitoring KAB, employing Education, Guidance and Counseling (education videos), and Surveillance (reminder messages), and assessing the outcomes.

  • Control Group

    Other intervention

    No intervention will be made to the patients in the control group, and the training videos prepared after the study is completed will be shared.

Treatment groups

112 Participants
are divided into 2 treatment groups
Group A: BUHOS appExperimental treatment 1 intervention
Group B: Control GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Omaha System- Problem Rating Scale for Outcomes Knowledge parameter

Time frame
15th and 30th day after intervention
2

Omaha System- Problem Rating Scale for Outcomes Behavior parameter

Time frame
15th and 30th day after intervention
3

Communicable Diseases Risk Awareness and Protection Scale (CDRAPS)

Time frame
15th and 30th day after intervention
4

Community Communicable Diseases Knowledge Survey

Time frame
15th and 30th day after intervention

Secondary outcomes

1

System Usability Scale (SUS)

Time frame
30th day after intervention

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kocaeli University

Lead sponsor

Atlas University

Collaborator

Istanbul Medeniyet University

Collaborator

Istanbul University - Cerrahpasa

Collaborator

Hatay Devlet Hastanesi

Collaborator

Health Institutes of Turkey

Collaborator

This trial is not recruiting at the moment. You can still explore other options: